This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Canaccord Genuity Hires Harrison Wehner As Managing Director; Continues Building Global Life Sciences Practice

Stocks in this article: CF

NEW YORK, Nov. 8, 2012 /PRNewswire/ - Canaccord Genuity is pleased to announce the continued expansion of its Life Sciences practice, adding senior investment banker, Harrison Wehner to its global team. Harrison joins Canaccord Genuity as a Managing Director focused on biotechnology and specialty pharmaceuticals and will be based at the firm's Boston office.

Over the past several months, Canaccord Genuity has significantly expanded its global Life Sciences practice with additions in the UK, Australia and the US. "We are very pleased to add Harrison's talent and experience to our growing Life Sciences practice," said Jeff Barlow, Managing Director and Head of US Investment Banking. "This is clearly a very interesting time in emerging therapeutics. We believe we have the team in place and expertise to play an increasingly active role in assisting companies in this sector with their financing and financial advisory needs."

Harrison Wehner joins Canaccord Genuity from Citigroup where he served as a Managing Director in the Global Healthcare Group in New York and London. Prior to Citigroup, Mr. Wehner held positions at UBS Investment Bank in London and UBS Warburg and PaineWebber in New York. Harrison has 17 years of experience in initiating and executing mergers, acquisitions and securities offerings for biotechnology and technology companies.

Harrison received an MBA from the Ross School of Business at the University of Michigan and a BA from the College of William and Mary.

With the addition of Harrison, Canaccord Genuity's global Life Sciences team consists of fifteen senior investment bankers located in five geographies: the US, Canada, UK, Australia and Asia. This banking team, combined with eight senior analysts and a specialized sales force in the sector, make Canaccord Genuity one of the leading investment banks focused on Life Science growth companies.

ABOUT CANACCORD GENUITY:

Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (TSX: CF, LSE: CF.), offering institutional and corporate clients idea-driven investment banking, merger and acquisition, research, sales and trading services from offices in 11 countries worldwide.  Our team of nearly 1,000 capital markets and advisory professionals has industry and transactional expertise in 18 key sectors of the global economy.  We are committed to providing valued services to our clients throughout the entire lifecycle of their business and operating as a gold standard independent investment bank - expansive in resources and reach, but targeted in industry expertise, market focus and individual client attention.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,908.82 +104.02 0.58%
S&P 500 2,070.90 +0.25 0.01%
NASDAQ 4,770.5190 +5.1390 0.11%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs